BMPs signal alternately through a SMAD or FRAP–STAT pathway to regulate fate choice in CNS stem cells
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The ability of stem cells to generate distinct fates is critical for the generation of cellular diversity during development. Central nervous system (CNS) stem cells respond to bone morphogenetic protein (BMP) 4 by differentiating into a wide variety of dorsal CNS and neural crest cell types. We show that distinct mechanisms are responsible for the generation of two of these cell types, smooth muscle and glia. Smooth muscle differentiation requires BMP-mediated Smad1/5/8 activation and predominates where local cell density is low. In contrast, glial differentiation predominates at high local densities in response to BMP4 and is specifically blocked by a dominant-negative mutant Stat3. Upon BMP4 treatment, the serine-threonine kinase FKBP12/rapamycin-associated protein (FRAP), mammalian target of rapamycin (mTOR), associates with Stat3 and facilitates STAT activation. Inhibition of FRAP prevents STAT activation and glial differentiation. Thus, glial differentiation by BMP4 occurs by a novel pathway mediated by FRAP and STAT proteins. These results suggest that a single ligand can regulate cell fate by activating distinct cytoplasmic signals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
Lagasse, E., Connors, H., Al-Dhalimy, M., Reitsma, M., Dohse, M., Osborne, L., Wang, X., Finegold, M., Weissman, I. L., & Grompe, M. (2000) · Nature Medicine · doi:10.1038/81326 · Cited by 2,314
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545 · cited 2×
“One possibility is that rapamycin may mimic an endogenous inhibitor of otherwise constitutively active FRAP (Gingras et al., 2001).”
BackgroundMammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 2×
“The serine-threonine kinase FRAP is an important regulator of cell growth and proliferation (Hentges et al., 2001; Fingar et al., 2002).”
BackgroundVilella-Bach, M., Nuzzi, P., Fang, Y., & Chen, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4266 · Cited by 154 · cited 5×
“FRAP defective in the FKBP12-rapamycin binding (FRB) domain, whereas Asp2357Glu point mutation deletes the kinase function of FRAP (Vilella-Bach et al., 1999).”
BackgroundInfluential
Cited by
GAGE: generally applicable gene set enrichment for pathway analysis
Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D., & Woolf, P. J. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-161 · Cited by 1,333
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
Hypoxia requires Notch signaling to maintain the undifferentiated cell state
Gustafsson, M. V., Zheng, X., Pereira, T., Gradin, K., Jin, S., Lundkvist, J., Ruas, J. L., Poellinger, L., Lendahl, U., & Bondesson, M. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.09.010 · Cited by 1,109
Dysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
Regulatory networks in embryo-derived pluripotent stem cells
Boiani, M., & Schöler, H. R. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1744 · Cited by 664
Kawase, E., Wong, M. D., Ding, B. C., & Xie, T. (2004) · Development · doi:10.1242/dev.01025 · Cited by 350
Serio, A., Bilican, B., Barmada, S. J., Ando, D. M., Zhao, C., Siller, R., Burr, K., Haghi, G., Story, D., Nishimura, A. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300398110 · Cited by 345
STAT‐mediated EGFR signaling in cancer
Quesnelle, K. M., Boehm, A. L., & Grandis, J. R. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21475 · Cited by 295
Adult Neurogenesis Requires Smad4-Mediated Bone Morphogenic Protein Signaling in Stem Cells
Colak, D., Mori, T., Brill, M. S., Pfeifer, A., Falk, S., Deng, C., Monteiro, R., Mummery, C., Sommer, L., & Götz, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4374-07.2008 · Cited by 266
Gerrard, L., Rodgers, L., & Cui, W. (2005) · STEM CELLS · doi:10.1634/stemcells.2005-0110 · Cited by 264
The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation
Bond, A. M., Bhalala, O. G., & Kessler, J. A. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22022 · Cited by 259
Rapamycin: an anti-cancer immunosuppressant?
Law, B. K. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.009 · Cited by 252
Progenitor cells of the testosterone-producing Leydig cells revealed
Davidoff, M. S., Middendorff, R., Enikolopov, G., Riethmacher, D., Holstein, A. F., & Müller, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200409107 · Cited by 252
The role of oxygen in regulating neural stem cells in development and disease
Panchision, D. M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21812 · Cited by 250
“…analysis, either by growing cells in culture at limiting dilution or by infecting cells/tissue with a low titer retroviral marker, so that all cells in a cluster can be identified as the progeny of a single original cell (i.e., a clone) (Johe et al., 1996; Rajan et al., 2003; Ravin et al., 2008).”
BackgroundSelf-citationChapter 21 Interleukin‐6 and Insulin Resistance
Kim, J., Bachmann, R. A., & Chen, J. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00621-3 · Cited by 224
“…to serine phosphorylate STAT3 in response to various stimuli under different cellular contexts, including PKCd ( Jain et al., 1999), JNK (Lim and Cao, 1999), ERK (Chung et al., 1997), MEK kinase 1 (MEKK1) (Lim and Cao, 2001), and mTOR (Kim et al., 2008; Rajan et al., 2003; Yokogami et al., 2000).”
TGF-β Family Signaling in Neural and Neuronal Differentiation, Development, and Function
Meyers, E. A., & Kessler, J. A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022244 · Cited by 202
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
Raje, N., Kumar, S., Hideshima, T., Ishitsuka, K., Chauhan, D., Mitsiades, C., Podar, K., Le Gouill, S., Richardson, P., Munshi, N. C., et al. (2004) · Blood · doi:10.1182/blood-2004-06-2281 · Cited by 187
Kim, J.-H., Kim, J. E., Liu, H.-Y., Cao, W., & Chen, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708568200 · Cited by 154
Townsend, K. L., Suzuki, R., Huang, T. L., Jing, E., Schulz, T. J., Lee, K., Taniguchi, C. M., Espinoza, D. O., McDougall, L. E., Zhang, H., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-199067 · Cited by 105
Kim, J.-H., Yoon, M.-S., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051516 · Cited by 92
Ara, J., See, J., Mamontov, P., Hahn, A., Bannerman, P., Pleasure, D., & Grinspan, J. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21462 · Cited by 79
“development (Gomes et al., 2003; Rajan et al., 2003; Bonaguidi et al., 2005), they may also participate in the generation of reactive astroglia in EAE.”
Influential
Metadata
- Authors
- Rajan, P., Panchision, D. M., Newell, L. F., & McKay, R. D. G.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2003-06-09
- Volume
- 161
- Issue
- 5
- Pages
- 911-921
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2146129235
- Cited by
- 207
- References
- 4
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.